More articles from Current Drug Therapy
- Hydroxychloroquine: An old drug with new relevance
This antimalarial drug is now approved to treat discoid lupus, systemic lupus erythematosus, and rheumatoid arthritis.
- Pharmacotherapy for obesity: What you need to know
Weight-loss drugs are not magic pills, but they can help when used along with diet, exercise, and other lifestyle changes.
Dual antiplatelet therapy for acute coronary syndromes: How long to continue?After drug-eluting stent placement, at least 12 months of dual antiplatelet therapy is recommended. Would longer be better?
- Ceftaroline fosamil: A super-cephalosporin?
Ceftaroline fosamil is the first beta-lactam with clinically useful activity against methicillin-resistant Staphylococcus aureus.
- Denosumab: A novel antiresorptive drug for osteoporosis
What denosumab is, how it works, how well it works, and practical prescribing tips.
Hepatitis C virus: Here comes all-oral treatmentDirect-acting antiviral drugs open the door for an all-oral regimen, potentially eliminating the need for interferon and thus avoiding its harsh side effects.
- Canagliflozin: Improving diabetes by making urine sweet
Canagliflozin is the first of a new class of diabetes drugs that lower glucose by increasing its urinary excretion. An overview of its mechanism, uses, risks, and benefits.
- A practical approach to prescribing antidepressants
Although antidepressant drugs do not differ much in their efficacy, a particular drug may be a better choice in a given patient.
Protease inhibitors: Silver bullets for chronic hepatitis C infection?These new drugs are a major step forward, and multidrug regimens that include them are the new standard of care.
- Bioidentical hormone therapy: Clarifying the misconceptions
Many women are turning to bioidentical hormone therapy on the basis of misconceptions, which we hope to clarify.